SA not planning to buy Merck Covid pill over cost – health official

The country’s health regulator SAHPRA said on Thursday that it had authorised use of molnupiravir.
Image: Bloomberg

The South African government is not planning to buy Merck’s COVID-19 treatment pill molnupiravir because an evaluation score from an advisory committee indicated it would not be cost-effective, senior health official Nicholas Crisp told Reuters.

The country’s health regulator SAHPRA said on Thursday that it had authorised use of molnupiravir.

COMMENTS   0

You must be signed in and an Insider Gold subscriber to comment.

SUBSCRIBE NOW SIGN IN

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Podcasts

Instrument Details  

You do not have any portfolios, please create one here.
You do not have an alert portfolio, please create one here.
INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us:

Search Articles:
Click a Company: